235 related articles for article (PubMed ID: 23816051)
1. HES1, a target of Notch signaling, is elevated in canine osteosarcoma, but reduced in the most aggressive tumors.
Dailey DD; Anfinsen KP; Pfaff LE; Ehrhart EJ; Charles JB; Bønsdorff TB; Thamm DH; Powers BE; Jonasdottir TJ; Duval DL
BMC Vet Res; 2013 Jul; 9():130. PubMed ID: 23816051
[TBL] [Abstract][Full Text] [Related]
2. Expression of hepatocyte growth factor and the proto-oncogenic receptor c-Met in canine osteosarcoma.
Fieten H; Spee B; Ijzer J; Kik MJ; Penning LC; Kirpensteijn J
Vet Pathol; 2009 Sep; 46(5):869-77. PubMed ID: 19429984
[TBL] [Abstract][Full Text] [Related]
3. Investigating CXCR4 expression in canine appendicular osteosarcoma.
Fan TM; Barger AM; Fredrickson RL; Fitzsimmons D; Garrett LD
J Vet Intern Med; 2008; 22(3):602-8. PubMed ID: 18466248
[TBL] [Abstract][Full Text] [Related]
4. Expression profiling in canine osteosarcoma: identification of biomarkers and pathways associated with outcome.
O'Donoghue LE; Ptitsyn AA; Kamstock DA; Siebert J; Thomas RS; Duval DL
BMC Cancer; 2010 Sep; 10():506. PubMed ID: 20860831
[TBL] [Abstract][Full Text] [Related]
5. Regulation of NOTCH signaling by reciprocal inhibition of HES1 and Deltex 1 and its role in osteosarcoma invasiveness.
Zhang P; Yang Y; Nolo R; Zweidler-McKay PA; Hughes DP
Oncogene; 2010 May; 29(20):2916-26. PubMed ID: 20208568
[TBL] [Abstract][Full Text] [Related]
6. Critical role of notch signaling in osteosarcoma invasion and metastasis.
Zhang P; Yang Y; Zweidler-McKay PA; Hughes DP
Clin Cancer Res; 2008 May; 14(10):2962-9. PubMed ID: 18483362
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of the surface exposed proteome of two canine osteosarcoma cell lines and normal canine osteoblasts.
Milovancev M; Hilgart-Martiszus I; McNamara MJ; Goodall CP; Seguin B; Bracha S; Wickramasekara SI
BMC Vet Res; 2013 Jun; 9():116. PubMed ID: 23758893
[TBL] [Abstract][Full Text] [Related]
8. Investigating TrkA expression in canine appendicular osteosarcoma.
Fan TM; Barger AM; Sprandel IT; Fredrickson RL
J Vet Intern Med; 2008; 22(5):1181-8. PubMed ID: 18638015
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of insulin-like growth factor-1 receptor is correlated with worse survival in canine appendicular osteosarcoma.
Maniscalco L; Iussich S; Morello E; Martano M; Gattino F; Miretti S; Biolatti B; Accornero P; Martignani E; Sánchez-Céspedes R; Buracco P; De Maria R
Vet J; 2015 Aug; 205(2):272-80. PubMed ID: 25257352
[TBL] [Abstract][Full Text] [Related]
10. Canine osteosarcoma: a naturally occurring disease to inform pediatric oncology.
Fenger JM; London CA; Kisseberth WC
ILAR J; 2014; 55(1):69-85. PubMed ID: 24936031
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-11 receptor alpha is expressed on canine osteosarcoma.
Sottnik JL; Thamm DH
Vet Comp Oncol; 2010 Jun; 8(2):96-102. PubMed ID: 20579322
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-199b-5p is involved in the Notch signaling pathway in osteosarcoma.
Won KY; Kim YW; Kim HS; Lee SK; Jung WW; Park YK
Hum Pathol; 2013 Aug; 44(8):1648-55. PubMed ID: 23574781
[TBL] [Abstract][Full Text] [Related]
13. Tumourigenic canine osteosarcoma cell lines associated with frizzled-6 up-regulation and enhanced side population cell frequency.
de Sá Rodrigues LC; Holmes KE; Thompson V; Newton MA; Stein TJ
Vet Comp Oncol; 2017 Mar; 15(1):78-93. PubMed ID: 25689105
[TBL] [Abstract][Full Text] [Related]
14. How the NOTCH pathway contributes to the ability of osteosarcoma cells to metastasize.
Hughes DP
Cancer Treat Res; 2009; 152():479-96. PubMed ID: 20213410
[TBL] [Abstract][Full Text] [Related]
15. Wnt10b activates the Wnt, notch, and NFκB pathways in U2OS osteosarcoma cells.
Mödder UI; Oursler MJ; Khosla S; Monroe DG
J Cell Biochem; 2011 May; 112(5):1392-402. PubMed ID: 21321991
[TBL] [Abstract][Full Text] [Related]
16. Notch signalling is off and is uncoupled from HES1 expression in Ewing's sarcoma.
Bennani-Baiti IM; Aryee DN; Ban J; Machado I; Kauer M; Mühlbacher K; Amann G; Llombart-Bosch A; Kovar H
J Pathol; 2011 Nov; 225(3):353-63. PubMed ID: 21984123
[TBL] [Abstract][Full Text] [Related]
17. Glucose transporter 1 expression in canine osteosarcoma.
Petty JC; Lana SE; Thamm DH; Charles JB; Bachand AM; Bush JM; Ehrhart EJ
Vet Comp Oncol; 2008 Jun; 6(2):133-40. PubMed ID: 19178673
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of p53 and retinoblastoma family pathways in canine osteosarcoma cell lines.
Levine RA; Fleischli MA
Vet Pathol; 2000 Jan; 37(1):54-61. PubMed ID: 10643981
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase-2 expression in canine appendicular osteosarcomas.
Mullins MN; Lana SE; Dernell WS; Ogilvie GK; Withrow SJ; Ehrhart EJ
J Vet Intern Med; 2004; 18(6):859-65. PubMed ID: 15638270
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical investigation of cell cycle and apoptosis regulators (survivin, β-catenin, p53, caspase 3) in canine appendicular osteosarcoma.
Bongiovanni L; Mazzocchetti F; Malatesta D; Romanucci M; Ciccarelli A; Buracco P; De Maria R; Palmieri C; Martano M; Morello E; Maniscalco L; Della Salda L
BMC Vet Res; 2012 Jun; 8():78. PubMed ID: 22686277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
